Share

May 26, 2015; 84 (21) Editorial

Escalating MS drug costs in the US

Puzzling, troubling, and suspicious

T. Jock Murray, Murray G. Brown
First published April 24, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001624
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
331

Share

Article Information

vol. 84 no. 21 2105-2106
DOI: 
https://doi.org/10.1212/WNL.0000000000001624
PubMed: 
25911109
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 24, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. T. Jock Murray, MD and
    2. Murray G. Brown, PhD
  1. T. Jock Murray, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Advisory Board of Medical Biography (UK)2002-Editorial Advisory Board of Canadian Journal of GeneralInternal Medicine 2005-

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Murray G. Brown, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Neurology (T.J.M.) and Department of Community Health and Epidemiology (T.J.M., M.G.B.), Dalhousie University and Capital District Health Authority, Nova Scotia, Canada.
  1. Correspondence to Dr. Murray: jock.murray{at}dal.ca
View Abstract

Article usage

Article usage: April 2015 to October 2023

AbstractFullPdfSource
Apr 2015808290Highwire
May 201510805898Highwire
Jun 20154562254Highwire
Jul 201512456Highwire
Aug 201576107Highwire
Sep 201515148Highwire
Oct 201529959Highwire
Nov 2015379710Highwire
Dec 201537012Highwire
Jan 201629953Highwire
Feb 201621020Highwire
Mar 201631233Highwire
Apr 201640310Highwire
May 201640303Highwire
Jun 201632311Highwire
Jul 201628210Highwire
Aug 201613600Highwire
Sep 20167723Highwire
Oct 20163901Highwire
Nov 20162511Highwire
Dec 20162700Highwire
Jan 20172800Highwire
Feb 20171900Highwire
Mar 20172506Highwire
Apr 20172721Highwire
May 20172102Highwire
Jun 2017911Highwire
Jul 2017400Highwire
Aug 2017832Highwire
Sep 2017901Highwire
Oct 20171601Highwire
Nov 20171310Highwire
Dec 20171000Highwire
Jan 20181102Highwire
Feb 2018521Highwire
Mar 2018600Highwire
Apr 20181031Highwire
May 20181410Highwire
Jun 20181801Highwire
Jul 20181400Highwire
Aug 20181211Highwire
Sep 20181800Highwire
Oct 20182300Highwire
Nov 20182701Highwire
Dec 20182101Highwire
Jan 20194801Highwire
Feb 20192400Highwire
Mar 20191500Highwire
Apr 20191800Highwire
May 20191200Highwire
Jun 2019800Highwire
Jul 20191701Highwire
Aug 20191801Highwire
Sep 2019600Highwire
Oct 2019922Highwire
Nov 20193211Highwire
Dec 2019620Highwire
Jan 20201500Highwire
Feb 20201310Highwire
Mar 20201000Highwire
Apr 2020300Highwire
May 20201500Highwire
Jun 20201000Highwire
Jul 2020400Highwire
Aug 2020910Highwire
Sep 20201610Highwire
Oct 20202400Highwire
Nov 20202010Highwire
Dec 20201100Highwire
Jan 2021800Highwire
Feb 20211200Highwire
Mar 20211500Highwire
Apr 20211100Highwire
May 20211600Highwire
Jun 2021910Highwire
Jul 20211400Highwire
Aug 20212100Highwire
Sep 2021800Highwire
Oct 20211900Highwire
Nov 20212800Highwire
Dec 20211611Highwire
Jan 2022621Highwire
Feb 20223400Highwire
Mar 20222300Highwire
Apr 20221800Highwire
May 20221900Highwire
Jun 20221100Highwire
Jul 2022702Highwire
Aug 2022600Highwire
Sep 20221500Highwire
Oct 20222610Highwire
Nov 2022900Highwire
Dec 2022900Highwire
Jan 20231110Highwire
Feb 2023500Highwire
Mar 2023400Highwire
Apr 20231000Highwire
May 2023800Highwire
Jun 20231200Highwire
Jul 20231000Highwire
Aug 20231200Highwire
Sep 2023600Highwire
Oct 20231700Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles